Science / Drugs MVST IB - part 1

Random Science Quiz

Can you name the drugs from MVST IB - part 1?

Quiz not verified by Sporcle

Forced Order
DescriptionDrug nameUse
SSRI - blocks 5-HT transporter in Uptake 1
Beta-1 antagonist used in heart failure
Competitive inhibitor of tyrosine hydroxylase
Inhibits HMG-CoA reductase - also many pleiotropic effects
Selective beta-2 antagonist (slight effect on beta-1)
Blocks transport of adenosine into cells - phosphodiesterase type V inhibitor
alpha-1 antagonist most commonly used
Experimental cardiac glycoside
Osmotic diuretic - filtered at glomerulus, not reabsorbed
Inodilator used to treat canine dilated cardiomyopathy - calcium sensitiser
K channel opener - also NO donor
Local anaesthetic - uncharged
Irreversible anticholinesterase - organophosphorus agent
Beta-adrenoceptor agonist
Inhibits DOPA decarboxylase in periphery
COMT inhibitor
Calcium channel blocker - benzothiazepine
Selective alpha-1 agonist (some action on beta-1)
Competitive antagonist for ganglionic nicotinic receptors - inactive at NMJ
Irreversibly alkylates muscarinic receptor
Binds very tightly to VMAT-2, preventing loading of catecholamines into vesicles
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Inhibits platelet activation by inhibiting binding of ADP to its receptor on platelets
Naturally occurring anticoagulant produced by basophils/mast cells - exposes active site of antithrombin III
Cholinergic agonist - +-isomer hydrolysed by AChE
Blocks transporter carrying ACh into storage vesicles
Very potent alpha-2 agonist
Non-specific endothelin receptor antagonist
Medium 'reversible' anticholinesterase - binds to esteratic site and carbamoylates ACh
Interferes with normal function of microtubule growth
Indirectly-acting sympathomimetic amine - weak inhibitor of MAO
Potent, irreversible inhibitor of iNOS in activated macrophages
Orally-acting hypoglycaemic agent - sulphonylurea
Class III antidysrhythmic - prolongs AP and refractory period
Partial agonist at alpha-adrenoceptors - 5-HT agonist
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Converted to alpha-methylNA - released as false transmitter - more potent at alpha-2, less potent at alpha-1
NOS inhibitor - not very selective for different forms
Combined alpha- and beta-adrenoceptor antagonist
Blocks Na channels from exterior - no use-dependence
K channel opener - also hirsutism effects
Selective non-depolarising neuromuscular blocking agent at NMJ - long action, not hydrolysed
Tricyclic antidepressant - blocks NET
A1 receptor antagonist - non-selective phosphodiesterase inhibitor
Reverse inhibition of AChE by organophosphorus agents
K channel opener
Mild partial beta-1 agonist
Local anaesthetic - weak base - use-dependence and voltage-dependence
Selective inhibitor of NOS in neurons
Alpha-2 antagonist (some effect on alpha-1)
Binds to neurexins, causing massive ACh release from nerve terminals
Direct acting vasodilator - metabolised to NO or cyanide
DescriptionDrug nameUse
Selective antagonist for M1 muscarinic receptors
Binds to plasminogen activator, increasing generation of plasmin
Acts on imidazoline receptors
Estrogen receptor antagonist
Selective MAO-A inhibitor
Quaternary local anaesthetic analogue - only effective if perfused inside cells
Nitrovasodilator - produces NO
Arteriolar vasodilator - unknown mechanism
Selective alpha-2 agonist
Class IC antidysrhythmic
Progestagen receptor agonist
Anion exchange resin - prevents reuptake of bile acids from intestine
Nicotinic receptor antagonist - relatively non-selective between NMJ and ganglion at clinical doses
Mineralocorticoid receptor antagonist - potassium-sparing diuretic
Single chain recombinant human tissue plasminogen activator
Competitive antagonist for ganglionic nicotinic receptor - inactive at NMJ
ADP-ribosylates alpha-i - prevents activation of Gi in response to stimulation
Blocks release of NA evoked by APs (repeated low doses/aftermath of large dose) - indirect sympathomimetic actions (large doses)
Irreversible antagonist at nicotinic NMJ receptors (no effect on ganglionic receptors)
Illegal drug - blocks NET
Irreversible alpha-adrenoceptor antagonist - blocks Uptake 2 (and Uptake 1 at 10x higher concs)
Monoclonal antibody against glycoprotein IIb/IIIa receptor - prevents platelet aggregation - also binds to vitronectin receptor
Calcium sensitiser - increases cardiac Ca2+ binding efficiency to troponin - inhibits phosphodiesterase III
Cardiac glycoside - inhibits Na/K-ATPase
Immunosuppressant drug with antiproliferative effects
Calcium channel agonist - dihydropyridine
ACE inhibitor - prodrug, must be metabolised in liver
Angiotensin II partial agonist
Cyclic heptapeptide inhibitor of glycoprotein IIb/IIIa receptor
Co-released with NA or ACh - acts on purinoceptors (P2 > P1)
Plasminogen + anisoylated streptokinase
Phosphodiesterase III inhibitor - inodilator
Beta-1 agonist - weak beta-2 agonist
Estrogen receptor agonist
Inhibits liver triglyceride production and VLDL secretion - increases levels of tissue plasminogen activator
Intracellular tetravalent polyamine - helps produce inward rectification of K+ channels
Tricyclic antidepressant - blocks NET
Local anaesthetic - slow onset/offset - use dependence at low rates of stimulation - class IA antidysrhythmic
Binds to synaptobrevin to prevent vesicle release from inhibitory interneuron synapses with motor neurons
PPAR-gamma agonist
Muscarinic receptor agonist
Inhibits intestinal absorption of cholesterol - circulates enterohepatically
Phosphodiesterase III inhibitor - inodilator
Blocks release of neurotransmitter via phospholipase A2 - localises to membrane by K channel binding moiety
Non-selective phosphodiesterase inhibitor
ACE inhibitor
Blocks uptake of choline into neurons
Cholinergic agonist - not selective between nicotinic/muscarinic receptors
Lowers VLDL (and LDL) by stimulating lipoprotein lipase - may activate PPARs
Double chain recombinant human tissue plasminogen activator
K channel opener
Depolarising blocker selective for NMJ nicotinic receptor - very short duration of action, broken down by BuChe - deficiency in enzyme activity can lead to prolonged action
DescriptionDrug nameUse
Irreversible anticholinesterase - activated by replacement of sulphur atom with oxygen, deoxified by plasma carboxylesterases
Glucocorticoid receptor antagonist
Reversible anticholinesterase - ionic interaction
Non-selective beta-adrenoceptor antagonist
Selective alpha-1 antagonist (slight effect on alpha-2)
Progestagen receptor antagonist
Non-selective phosphodiesterase inhibitor
Calcium channel antagonist - dihydropyridine - affects L-type but not T-type channels
Calcium channel blocker - phenylalkylamine - class IV antidysrhythmic
Selective alpha-2 antagonist (slight effect on alpha-1)
Involved with providing new blood flow to ischaemic tissues
Selective beta-2 agonist (slight effect on beta-1)
Selective inhibitor of phosphodiesterase type V (selectively breaks down cGMP)
Uncompetitive inhibitor of phosphatase acting on IP1 --> inositol
Slightly selective alpha-2 agonist (also alpha-1 actions) - omitting dose can lead to rebound hypertension
Causes development of new blood vessels
Non-selective, reversible MAO inhibitor
Blocks If current in SA node
Non-peptide angiotensin II antagonist - acts on AT1 receptors
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Regulates expression of multiple angiogenic genes
Local anaesthetic (ester, weak base) - broken down by BuChE
ADP-ribosylates alpha-s - inhibits GTPase activity - sustained activation of adenylyl cyclase
Nitrovasodilator - produces NO - taken sublingually
Selective MAO-B inhibitor
NSAID used to prevent thrombosis
Non-selective agonist for muscarinic receptors
Acts on imidazoline receptors
Muscarinic receptor antagonist - very long duration of action
Loop diuretic - blocks Na/K/2Cl transport in thick ascending limb
Non-selective agonist for muscarnic receptors
Tyrosine kinase inhibitor
Indirectly acting sympathomimetic amine - converted to octopamine by DBH - found in various foodstuffs
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Orally-acting hypoglycaemic agent - sulphonylurea
Carbonic anhydrase inhibitor
Thiazide diuretic - blocks Na/Cl transport in early distal tubule
Inhibits clotting by inhibiting synthesis of factors II, VII, IX, IX and regulatory proteins C, S, Z
Binds to SNAREs involved in membrane fusion, preventing ACh release
Nitrovasodilator - produces NO - metabolised in liver to active drug
Non-peptide inhibitor of glycoprotein IIb/IIIa receptor
Selective non-depolarising neuromuscular blocker at NMJ - ester, broken down by spontaneous hydrolysis and plasma esterases
Selective antagonist for M3 muscarinic receptor
Beta-1 antagonist used in heart failure
Mineralocorticoid receptor agonist
Glucocorticoid receptor agonist
Selective beta-1 antagonist (slight effect on beta-2)
Use-dependent block of ganglionic transmission
Used experimentally to inhibit dopamine beta-hydroxylase - also inhibits aldehyde dehyddrogenase
Depolarising blocker selective for ganglion nicotinic receptor
Non-selective alpha-adrenoceptor antagonist
Depolarising blocker at NMJ

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
Log In

You Might Also Like...

Show Comments


Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.